Useful resources |
Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease (Cochrane Review) ABSTRACT Background: Inhaled short acting beta2 adrenergic agonists and ipratropium bromide are both used in the treatment of acute exacerbations of chronic obstructive pulmonary disease. |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |